Date: November 30, 2012
About: SWHR convened an international group of preeminent researchers to examine the evidence for and against menopausal hormone therapy, and provide directions for future research. This roundtable was a closed meeting, but SWHR has provided a summary report of the meeting and press release.
The researchers were organized into five important subgroups: cardiovascular disease, Alzheimer’s disease and cognitive aging, osteoporosis, cancer, and quality of life. Each subgroup will come prepared with the following:
- Best level of evidence
- Risks relative to endpoints
- Future research recommendations